Clinical Trial market research reports by DelveInsight

• Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator development. The repor ... Read More

• Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  “Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor development. The repor ... Read More

• AXL Inhibitors - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 2,000

  DelveInsight’s, “AXL Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 16+ companies and 20+ pipeline drugs in AXL Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More

• TCR Therapy- Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 3,000

  DelveInsight’s, “TCR Therapy- Pipeline Insight, 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in TCR Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessm ... Read More

• Refractory Metastatic Melanoma - Pipeline Insight, 2025

  Apr 01, 2025  |  Published by: DelveInsight  |  USD 1,250

  DelveInsight’s, “Refractory Metastatic Melanoma - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Refractory Metastatic Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More

• Endothelin Receptor Antagonist - Pipeline Insight, 2025

  Mar 01, 2025  |  Published by: DelveInsight  |  USD 2,000

  DelveInsight’s, “Endothelin Receptor Antagonist - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Endothelin Receptor Antagonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• Molecular Glues - Competitive landscape, 2025

  Mar 01, 2025  |  Published by: DelveInsight  |  USD 2,500

  DelveInsight’s, “Molecular Glues - Competitive landscape, 2025,” report provides comprehensive insights about 50+ companies and 65+ drugs in Molecular Glues Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further hi ... Read More

• AXL Inhibitors - Pipeline Insight, 2025

  Mar 01, 2025  |  Published by: DelveInsight  |  USD 2,000

  DelveInsight’s, “AXL Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 16+ companies and 20+ pipeline drugs in AXL Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More

• Comprehensive Analysis of PCOS: Epidemiology , Patient Journey, Market Trends, Unmet Needs, and Glycemic Management

  Feb 06, 2025  |  Published by: DelveInsight  |  USD 8,000

  Read More

• Interventional Neuroradiology - Market Insights, Competitive Landscape, and Market Forecast - 2032

  Feb 01, 2025  |  Published by: DelveInsight  |  USD 3,750

  Interventional Neuroradiology Market by Device (Micro guidewires, Microcatheters, Flow Diversion Stents, Embolization Coils, Neurovascular Embolization Devices, and Others), Disease (Cerebral Aneurysms, Intra-cranial Tumors, Acute Ischemic Strokes, and Other Diseases), End-Users (Hospitals, Ambulato ... Read More

• Schizophrenia - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Schizophrenia - Pipeline Insight, 2024 DelveInsight’s, “Schizophrenia- Pipeline Insight, 2024” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage product ... Read More

• Lou Gehrig’s disease - Pipeline Insight, 2024

  Nov 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Lou Gehrig’s disease - Pipeline Insight, 2024 DelveInsight’s, “Lou Gehrig’s disease - Pipeline Insight, 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Lou Gehrig’s disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non ... Read More

• Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Bronchiectasis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Chronic Obstructive Pulmonary Disease (COPD) market was valued at USD 16,075 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). This growth is primarily d ... Read More

• Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Down’s syndrome is a genetic condition caused by an error in cell division called ""nondisjunction,"" resulting in an individual having a full or partial extra copy of chromosome 2 ... Read More

• Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034

  Oct 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Myotonic Dystrophy Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 2,718 thousand diagnosed prevalent cases of Parkinson’s disease in the 7MM. Of these, the United States accounted for 45% of the cases, w ... Read More

• Congenital Adrenal Hyperplasia Market Insight, Epidemiology And Market Forecast - 2034

  Aug 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Congenital Adrenal Hyperplasia Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Traumatic Brain Injury market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of Traumatic Brain Injury in the 7MM is expected to increase, ... Read More

• Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024

  Aug 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024 DelveInsight’s, “Chronic rhinosinusitis with nasal polyps - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Chronic rhinosinusitis with nasal polyps pipeline landscape. It co ... Read More

• Lichen Planus- Pipeline Insight, 2024

  Aug 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Lichen Planus- Pipeline Insight, 2024 DelveInsight’s, “Lichen Planus- Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Lichen Planus pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• Primary Ciliary Dyskinesia Market Insight, Epidemiology And Market Forecast - 2034

  Aug 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Primary Ciliary Dyskinesia Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size in the 7MM for Developmental and Epileptic Encephalopathy (DEE) was estimated to be nearly USD 2,100 million in 2023, which is expected to grow with a significant CAGR during the f ... Read More

• Congenital Hyperinsulinism - Pipeline Insight, 2024

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Congenital Hyperinsulinism - Pipeline Insight, 2024 DelveInsight’s, “Congenital Hyperinsulinism - Pipeline Insight, 2024” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Congenital Hyperinsulinism pipeline landscape. It covers the pipeline drug profiles, including ... Read More

• Enzyme Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Enzyme Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 Enzymes Contract Manufacturing Market By Source (Plant, Animal, Microbe), Application (Industrial Enzymes [Food And Beverages, Animal Feed, Detergent, Paper And Others], Specialty Enzymes [Pharmaceutic ... Read More

• Ophthalmic Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Ophthalmic Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 Ophthalmic Drugs Market By Product Type (Prescription Drugs And Over-The-Counter Drugs), By Indication (Dry Eyes, Eye Allergy, Glaucoma, Retinal Disorders, And Others), By Drug Class (Anti-Allergic, Anti-Inflammato ... Read More

• Keratoconus - Pipeline Insight, 2024

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Keratoconus - Pipeline Insight, 2024 DelveInsight’s, “Keratoconus - Pipeline Insight, 2024” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Keratoconus pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It a ... Read More

• Mydriasis - Epidemiology Forecast - 2034

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Mydriasis - Epidemiology Forecast - 2034 Key Highlights DelveInsight's analysis anticipates that among EU4 and the UK, Germany had the highest cases of eye exams and ophthalmic surgeries, with nearly 29 million cases in 2023. Out of the total surgeries, cataract surgery accounted for the highest wit ... Read More

• Bladder cancer – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Bladder cancer – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Bladder cancer – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Bladder cancer, historical and forecasted epidemiology as well as the Bladder cance ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >